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Abstract
Background—Neurodevelopmental models of schizophrenia suggest that cognitive deficits may
be observed during childhood and adolescence, long before the onset of psychotic symptoms.
Elucidating the trajectory of normal cognitive development during childhood and adolescence may
therefore provide a basis for identifying specific abnormalities related to the development of
schizophrenia. The MATRICS Consensus Cognitive Battery (MCCB), which was designed for use
in clinical trials targeting cognitive deficits most common in schizophrenia, may provide a
mechanism to understand this trajectory. To date, however, there is no performance data for the
MCCB in healthy children and adolescents. The present study sought to establish performance
data for the MCCB in healthy children, adolescents, and young adults.
Methods—The MCCB was administered to a community sample of 190 healthy subjects
between the ages of 8 and 23 years. All MCCB domain scores were converted to T-scores using
sample means and standard deviations and were compared for significant performance differences
between sex and age strata.
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Results—Analyses revealed age effects following quadratic trends in all MCCB domains, which
is consistent with research showing a leveling off of childhood cognitive improvement upon
approaching late adolescence. Sex effects after controlling for age only presented for one MCCB
domain, with males exhibiting well-known spatial reasoning advantages.
Conclusions—Utilizing this performance data may aid future research seeking to elucidate
specific deficits that may be predictive of later development of SZ.
Keywords
Cognition; Schizophrenia; Pediatric; Neurodevelopment; Neuropsychology
Introduction
The National Institute of Mental Health (NIMH), with the Food and Drug Administration
(FDA) and pharmaceutical industry representatives, developed The Measurement and
Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus
Cognitive Battery (MCCB) with a series of sponsored consensus conferences (Nuechterlein
et al., 2008). The goal of these efforts was to aid in the development of cognitive-enhancing
medications that might target the schizophrenia-related cognitive deficits linked to poor
functional outcomes (Green et al., 2004). The MCCB is composed of 10 independently-
developed and separately-published tests assessing several cognitive domains. Although
each MCCB subtest has been normed on its own, a neurocognitive battery comprised of
independently-developed tests can operate differently than the individual tests comprising
the battery (Russell et al., 2005). Test-order, practice, and fatigue effects can all change
when individual tests become systematically administered within a larger battery.
Furthermore, probability for a false-positive score in the abnormal range increases with
number of tests administered. Consequently, performance data based on a single test
administered alone can be invalid for a test battery (Ingraham and Aiken, 1996). Scores in
conceptually-related cognitive domains are also bound to be directly compared in search of
deficits, but to accurately make such comparisons, scores must be standardized to the same
measurement scale and remain stable across demographic strata (Russell et al., 2005). For
these reasons, the MCCB was co-normed to ensure the battery’s reliability and validity as a
whole.
Although MCCB co-norms are established in healthy adults (Kern et al., 2008) and
schizophrenia patients (Green et al., 2008), comparative youth performance data has not yet
been established. Assessing youths’ MCCB performance is critical given
neurodevelopmental models of cognitive change in schizophrenia. Cognitive impairment is a
core feature of schizophrenia (Reichenberg, 2010) and deficits may present long before
symptom onset (Bilder et al., 2006; Brewer et al., 2005; Cornblatt et al., 2003; Cullen et al.,
2010; Lewis and Levitt, 2002; MacCabe, 2008; Reichenberg et al., 2002; Tiihonen et al.,
2005). The MCCB has also evidenced sensitivity to cognitive differences between
adolescent healthy controls and adolescents with early-onset schizophrenia (Holmén et al.,
2010) demonstrating the applicability of administering the MCCB with young populations.
Understanding MCCB performance data in youth could provide a much needed mechanism
for assessing cognitive trajectories across neurodevelopment, which may be critical to
understanding schizophrenia etiology (e.g. at-risk and early onset cohorts) and evaluating
childhood schizophrenia treatments.
Our study sought to evaluate MCCB performance in healthy children, adolescents, and
young adults, and examine whether performance differs between sexes and age groups.
Findings could supply the performance data necessary to correct MCCB scores based on age
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and sex strata in at-risk and psychiatrically-ill youths. Such data might allow for more
precise assessment of the cognitive deficits predating schizophrenia onset.
Methods
Participants
Our sample consisted of 190 healthy volunteers aged 8–23 (mean = 16.55 ± 4.0) recruited
by newspaper and Internet advertisements, posted flyers, or personal referrals from the
general population in a region bridging urban New York City with suburban Long Island.
Age ranges were selected based on a meta-analysis evaluating cognitive age effects in
healthy youths (Romine and Reynolds, 2005). Age ranges included 1) 8–11, n=24 (12.6%),
2) 11–14, n=21 (11.1%), 3) 14–17, n=54 (28.4%), 4) 17–20, n=46 (24.2%), and 5) 20–23,
n=45 (23.7%) year-olds. Regarding socioeconomic status, n=35 (19.8%) were upper-class,
n=64 (36.2%) were upper-middle-class, n=49 (27.7%) were middle-class, and n=29 (16.4%)
were lower-middle-class or below; n=13 (6.8%) did not disclose socioeconomic status. For
full demographic data, see Table 1. All participants over 18 provided written informed
consent; all minors provided assent alongside parental written informed consent to a
protocol approved by the Institutional Review Board of North Shore-Long Island Jewish
Health System. Participants were excluded if they had a past or present Axis-I diagnosis,
active or recent (within the past month) substance abuse, intellectually disability, incidence
of head injury with loss of consciousness (for any amount of time), medical illnesses that
could affect brain functioning, or were taking medications with known cognitive effects (e.g.
psychostimulants, antipsychotics, cholinesterase inhibitors). Adults were excluded if they
had first-degree relatives with known or suspected Axis-I disorders. Children were excluded
if they had first-degree relatives with known or suspected major depressive disorder, bipolar
disorder, or psychotic disorder.
Clinical assessments
To rule out Axis-I disorders, participants over age 16 were administered the Structured
Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Non-
Patient Version (SCID-NP; First et al., 1995). Participants under age 16 were administered
the Kiddie-Schedule for Affective Disorders and Schizophrenia - Present and Lifetime
Version (K-SADS-PL; Kaufman et al., 1997). SCID-NP and K-SADS-PL screeners and
diagnostic modules were conducted by licensed psychologists or by trained undergraduate-
level or graduate-level research assistants supervised by a licensed psychologist. SCID-NP
information was compiled into narrative case summaries and absence of pathology was
determined in consensus conferences by two expert diagnosticians. The K-SADS-PL and
SCID-NP have demonstrated strong test-retest reliability, with kappa coefficients ranging
from 0.67-to-1.00 for K-SADS-PL (Kaufman et al., 1997) and 0.92 for SCID-NP
(Stukenberg et al., 1990).
Neurocognitive assessment
MCCB—All MCCB tests were administered except the Mayer-Salovey Emotional
Intelligence Test (MSCEIT; Mayer, 2002) because a MSCEIT youth-version had not been
adequately validated at the time of data collection. Thus, MCCB subtests fell into six instead
of seven domains. Our battery consisted of 9 subtests assessing six cognitive domains,
including 1) Processing Speed, measured by the symbol coding subtest of the Brief
Assessment of Cognition in Schizophrenia (BACS Symbol Coding; Keefe et al., 2004), the
Trail Making Test: Part A (Trails-A; Army Individual Test Battery, 1944), and Category
Fluency: Animal Naming (Animal Naming; Spreen and Strauss, 1998), 2) Attention/
Vigilance, measured by the Continuous Performance Test – Identical Pairs (CPT-IP;
Cornblatt et al., 1988), 3) Working Memory, measured by the spatial span subtest of the
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Wechsler Memory Scale, Third Edition (WMS-III Spatial Span; Wechsler, 1997) and Letter
Number Span (LNS; Gold et al., 1997), 4) Verbal Learning, measured by the Hopkins
Verbal Learning Test – Revised (HVLT-R; Brandt and Benedict, 2001), 5) Visual Learning,
measured by the Brief Visuospatial Memory Test – Revised (BVMT-R; Benedict, 1997), and
6) Reasoning and Problem Solving, measured by the Neuropsychological Assessment
Battery mazes subtest (NAB Mazes; Stern and White, 2003).
Pubertal development—To control influence from sexual development on cognitive
performance, the widely-used Tanner stages scale of pubertal development (Tanner, 1962)
was administered. This scale asks subjects to look at drawings depicting bodies in various
stages of pubertal development and identify their stage, resulting in subscales measuring 1)
body structure and 2) pubic hair development.
Data Analysis
MCCB scoring and standardization—Analyses were conducted using the same
methodology as Kern et al. (2008) except for the MSCEIT being excluded (see above). The
remaining nine MCCB subtests were assessed for normality of their distributions, and
notably skewed variables were corrected using logarithmic transformation; only one
subscale, Trails-A, was skewed and required this logarithmic transformation. Raw scores
were then standardized to T-scores using the full sample of 190 healthy subjects. Scores on
Trails-A were also reversed so longer completion times properly denoted weaker
performance. Adhering to the Kern et al. (2008) methodology, summary scores were
computed for MCCB cognitive domains with greater than one subscale by summing the T-
scores of those subscales and standardizing those sums to T-scores. Similarly, the overall
composite score for global cognition was computed by summing the T-scores for all nine
subtests and standardizing this sum to a T-score. Thus, all MCCB domains were
standardized to the same measurement scale (mean=50; standard deviation=10).
Statistical analyses—The sample was analyzed using independent samples t-tests to
examine sex differences in MCCB performance and one-way analyses of variance
(ANOVAs) to examine MCCB performance differences between age groups. All tests were
two-tailed. Cognitive capacity was hypothesized to show a quadratic curve as it increases
throughout childhood and levels off into late adolescence (Romine and Reynolds, 2005).
Thus for all statistically significant age effects, follow-up polynomial contrasts were
analyzed for quadratic trends.
Results
Age effects
One-way ANOVAs showed significant age effects on subjects’ performance in all MCCB
domains and overall performance on the MCCB (processing speed: F=34.08, df=4, 183,
p<0.001; attention/vigilance: F=37.05, df=4, 176, p<0.001; working memory: F=12.61,
df=4, 184, p<0.001; verbal learning, F=3.76, df=4, 184, p<0.01; visual learning, F=4.63,
df=4, 179, p<0.01; reasoning and problem solving, F=11.76, df=4, 182, p<0.001; overall
composite score, F=27.70, df=4, 173, p<0.001). All assumptions for ANOVAs were met
except in the verbal learning and visual learning domains, which were both significant on
Levene’s test (verbal learning: F=3.06, p=0.018; visual learning: F=3.00, p=0.02). Thus, two
Welch’s tests were performed which also found significant age effects (verbal learning:
Welch’s F=2.75, p<0.05; visual learning: Welch’s F=3.42, p<0.05), confirming that these
ANOVA findings were not merely due to heterogeneity of variances between groups. Post-
hoc polynomial contrasts on age groups confirmed significant quadratic trends for all
MCCB domains, as cognitive capacities increased throughout childhood and leveled off
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approaching late adolescence and young adulthood (processing speed: F=19.22, df=1, 183,
p<0.001; attention/vigilance: F=8.37, df=1, 176, p<0.01; working memory: F=6.62, df=1,
184, p<0.01; verbal learning, F=3.97, df=1, 184, p<0.05; visual learning, F=9.95, df=1, 179,
p<0.01; reasoning and problem solving, F=18.28, df=1, 182, p<0.001; overall composite
score, F=26.48, df=1, 173, p<0.001).
The potential impact of adolescent sexual development on cognitive performance was next
ruled out using Tanner pubertal stage data (Tanner, 1962). Results found Tanner stages’
body structure and pubic hair were not significantly associated with the MCCB overall
composite score in the presence of age (Tanner body structure: β=0.76, p=0.435; Tanner
pubic hair: β= −0.65, p=0.552; age: β=6.32, p=7.83 × e−006).
Furthermore, to be consistent with Kern et al. (2008), observed age effects were confirmed
using regression-based T-scores, which were calculated in line with the regression-based
approach of the MCCB computer scoring program. Specifically, regression-based T-scores
were generated by regressing age and sex on subtest raw scores to produce predicted values
that were subtracted from each subtest raw score before converting to T-scores. Regression-
based T-scores are not dependent on sample size as they are generated based upon expected
change over time. Since our data included some age groups with small sample sizes,
ANOVAs were re-run using regression-based T-scores, which confirmed observed age
effects showing quadratic trends. For a full age effects summary, see Table 2 and Figure 1.
Table 2 includes two different metrics, with the top half displaying community-sample-
based T-scores derived using calculations that are common across all ages and the bottom
half displaying regression-based calculations that adjust for age.
Sex effects
Independent samples t-tests evidenced ;only one significant sex difference in test
performance: males evidenced significantly higher performance on the reasoning and
problem solving task (i.e. NAB Mazes) compared to females (t=3.24, df=2, 181, p≤.001).
Given significant age effects across all MCCB domains, a follow-up ANCOVA was
conducted to ensure sex effects would remain significant after controlling for age. Indeed,
even after controlling for age, males showed significantly higher performance on the
reasoning and problem solving domain (F=12.34, df=1, 183, p<0.001). No other significant
sex differences were found. For a full sex effects summary, see Table 3.
Discussion
The present study extends data on adults’ MCCB performance to include a child, adolescent,
and young adult sample. This youth performance data may provide common reference and
comparison group when assessing cognitive changes in the development of schizophrenia.
Moreover, these data may provide a better understanding of schizophrenia as a
neurodevelopmental disorder via future studies of youths using the MCCB’s targeted
assessment of cognitive domains impacted by schizophrenia.
A primary finding was that significant MCCB performance differences were found between
age groupings. Specifically, performance in all MCCB domains followed quadratic trends,
where scores tended to show marked cognitive improvement in childhood, followed by mild
cognitive improvement in early adolescence, and a leveling-off for subjects in late
adolescence and early adulthood. These age effects are consistent with past meta-analytic
research showing strong cognitive improvement during childhood, moderate improvement
in adolescence, and only slight improvement in late adolescence and young adulthood
(Romine and Reynolds, 2005).
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In addition, even after controlling for age, males performed significantly better than females
on the reasoning and problem solving domain of the MCCB, which consists of a timed task
requiring subjects to complete increasingly difficult mazes. This finding is consistent with
past research showing cognitive advantages for males on spatial reasoning tasks (Geary et
al., 2000), which perhaps conferred an advantage for our male subjects when tasked with
completing mazes.
Our study was limited by a relatively small sample size of 190 subjects. In addition, unlike
the original Kern et al. (2008) study, our study did not use a scientific sampling method but
rather recruited subjects using posted flyers and advertisements. Collecting a community
sample may have contributed to some ways our sample differed from the population-at-
large, including somewhat smaller N’s in our younger age groups and that our sex
distribution varied somewhat across age groups (ranging from 46.3% to 62.2% female). Our
study also had smaller samples of 8–11 and 11–14 year-olds and a disproportionate number
of African-Americans in the 8–11 year-old age group. Due to these limitations, our study
may have been subject to sampling bias and small sample size, making results less
generalizable than studies with scientific sampling methods and larger, more geographically-
diverse samples that are more representative of the population-at-large. Follow-up studies
are therefore needed to examine MCCB performance in larger and more geographically
diverse samples, with particular focus on 8–11 and 11–14 year-olds. However, age effects
were confirmed with regression-based T-scores, which helped attenuate the limitation of
small sample size. Moreover, evaluating MCCB performance in youth remains critically
important, and our study’s sampling method, sampling distribution, and sample size are
comparable to (and regarding sample size, in some cases larger than) past studies aimed at
establishing child performance data on neuropsychology tests or extending
neuropsychological tasks to include younger age ranges (Courtney et al., 2003; Epsy and
Cwik, 2004; Luciana and Nelson, 2002; Piper et al., 2010).
While the MSCEIT was excluded from our study, the BACS Symbol Coding, NAB Mazes,
WMS-III Spatial Span, and LNS tasks, also lacked norms for subjects under age 16 but were
still included. This decision was based on our assessment of each task’s complexity or the
extent of the task’s similarity to other validated measures. Specifically, the BACS Symbol
Coding and LNS tasks are nearly identical to the validated Digit-Symbol Coding and Letter-
Number Sequencing tasks of the Wechsler Intelligence Scale for Children – Fourth Edition
(WISC-IV; Wechsler, 2003). In addition, instructions for NAB Mazes and WMS-III Spatial
Span were judged to be easily comprehended by children, as NAB Mazes asks subjects to
complete timed mazes while WMS-III Spatial Span asks subjects to touch blocks in the
same order as the examiner and then in reverse order. This is quite different from the
MSCEIT requiring subjects have the ability to envision adult life scenarios such as engaging
in office politics and being cut off in traffic. Thus, although younger children would likely
display poorer performance on these cognitive tasks, it was also likely they would be able to
understand and adhere to task instructions, whereas the MSCEIT was substantially less
likely to be comprehensible for young subjects. Furthermore, past child and adolescent
norms were within one standard deviation of our data except for Trails-A, where adolescents
were within one standard deviation but 8–13 year-olds showed poorer Trails-A performance
compared with 1969, 1994, and 1995 norms (Baron, 2004). However, all our data was
within one standard deviation of more recent MCCB performance in a 12–18 year-old
control group (Holmén et al., 2010). Regardless, our study is limited by the lack of a social
cognition measure, such as the MSCEIT, which negatively impacts the usefulness of the
present data in identifying the relative contribution of social cognition to schizophrenia
etiology.
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Our study may also be limited by statistical issues regarding heterogeneity of variances
between groups. Both Verbal Learning and Visual Learning showed significance on
Levene’s test while examining age effects, and thus effects could have been impacted by
differences in N between age groups. Indeed, both these domains had more subjects over
versus under age 14 (verbal learning: 8–11 years (n=24), 11–14 years (n=21), 14–17 years
(n=54), 17–20 years (n=45), 20–23 years (n=41); visual learning: 8–11 years (n=23), 11–14
years (n=21), 14–17 years (n=51), 17–20 years (n=45), 20–23 years (n=40)). However, two
Welch’s tests, which do not assume equality of variances, confirmed our age effects. Present
data are also congruent with past research suggesting adolescents over age 14 show less
cognitive change than younger age groups (Romine and Reynolds, 2005) and thus observed
variances between age groups may merely reflect this shift.
We should note our study uses T-scores differently from how they are typically used in other
contexts, such as in school settings or during learning disability evaluations. Typically, T-
scores are applied in contexts where each individual’s performance is being compared
against demographically-matched peers; in these contexts, using age as an example, T-
scores would typically compare individuals against same-age peers, and thus would be
standardized within each age group rather than across all age groups. However, the purpose
of our study was assess child and adolescent performance the MCCB by standardizing T-
scores across (and not within) all age and sex strata. Thus, participants aged 8–11 displayed
“low” T-scores not because they have performance deficits compared to other 8–11 year-
olds, but rather because their T-scores are lower compared to older children, teens, and
young adults. The same is true for sex strata used in the present study. Thus, to aid future
studies and replication efforts, unadjusted means and standard deviations are provided for
the raw scores on all MCCB subtests in Table 4.
In summary, these data may provide researchers with the performance data needed for
demographic correction of the MCCB with children and teens, which in turn may provide
the greater accuracy and specificity needed to pinpoint neurocognitive precursors to
schizophrenia across child and adolescent development. Such precursors can assist in early
prevention efforts as well as in the assessment of childhood schizophrenia treatments and the
development of cognition enhancing psychotropic medications to combat cognitive
deterioration in schizophrenia.
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Figure 1.
Age effects on MCCB performance
Note: Community-sample-based T-scores are derived from community sample means and
standard deviations.
Nitzburg et al. Page 10
Schizophr Res. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Nitzburg et al. Page 11
Ta
bl
e 
1
D
em
og
ra
ph
ic
 d
at
a 
by
 a
ge
 g
ro
up
A
ge
 G
ro
up
s
8–
11
 y
 (n
=2
4)
11
–1
4 
y 
(n
=2
1)
14
–1
7 
y 
(n
=5
4)
17
–2
0 
y 
(n
=4
6)
20
–2
3 
y 
(n
=4
5)
To
ta
l (n
=1
90
)
%
 F
em
al
e
58
.3
%
57
.1
%
46
.3
%
47
.8
%
62
.2
%
53
.2
%
Et
hn
ic
ity
 
A
sia
n
1 
(4.
1%
)
3 
(14
.3%
)
6 
(11
.1%
)
4 
(8.
7%
)
4 
(8.
9%
)
18
 (9
.5%
)
 
A
fri
ca
n-
A
m
er
ic
an
8 
(33
.3%
)
5 
(23
.8%
)
11
 (2
0.4
%)
11
 (2
3.9
%)
7 
(15
.6%
)
42
 (2
2.1
%)
 
H
isp
an
ic
/L
at
in
o
2 
(8.
3%
)
0 
(0%
)
5 
(9.
3%
)
2 
(4.
3%
)
7 
(15
.6%
)
16
 (8
.4%
)
 
Ca
uc
as
ia
n
10
 (4
1.6
%)
12
 (5
7.1
%)
28
 (5
1.9
%)
27
 (5
8.7
%)
25
 (5
5.6
%)
10
2 
(53
.7%
)
 
O
th
er
3 
(12
.5%
)
1 
(4.
7%
)
4 
(7.
4%
)
2 
(4.
3%
)
2 
(4.
4%
)
12
 (6
.3%
)
So
ci
oe
co
no
m
ic
 S
ta
tu
s
 
U
pp
er
 C
la
ss
5 
(20
.8%
)
5 
(23
.8%
)
6 
(11
.1%
)
9 
(19
.6%
)
10
 (2
2.2
%)
35
 (1
9.8
%)
 
U
pp
er
-M
id
dl
e 
Cl
as
s
5 
(20
.8%
)
6 
(28
.6%
)
19
 (1
6.7
%)
17
 (3
7.0
%)
17
 (3
7.8
%)
64
 (3
6.2
%)
 
M
id
dl
e 
Cl
as
s
7 
(29
.1%
)
5 
(23
.8%
)
17
 (3
1.5
%)
10
 (2
1.7
%)
10
 (2
2.2
%)
49
 (2
7.7
%)
 
≤ 
Lo
w
er
-M
id
dl
e 
Cl
as
s
7 
(29
.1%
)
4 
(19
.1%
)
8 
(14
.8%
)
4 
(8.
7%
)
6 
(13
.3%
)
29
 (1
6.4
%)
 
D
id
 N
ot
 D
isc
lo
se
0 
(0%
)
6 
(28
.6%
)
7 
(13
.0%
)
0 
(0%
)
0 
(0%
)
13
 (6
.8%
)
Schizophr Res. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Nitzburg et al. Page 12
Ta
bl
e 
2
A
ge
 e
ffe
ct
s s
ho
w
in
g 
qu
ad
ra
tic
 tr
en
ds
 o
n 
M
CC
B 
do
m
ai
ns
 u
sin
g 
co
m
m
un
ity
-s
am
pl
e-
ba
se
d 
T 
sc
or
es
 a
nd
 re
gr
es
sio
n-
ba
se
d 
T-
sc
or
es
M
C
C
B 
C
om
m
un
ity
-S
am
pl
e-
Ba
se
d 
T-
Sc
or
e
A
ge
 G
ro
up
s:
 U
na
dju
ste
d M
ea
ns
 (±
SD
)
St
at
ist
ic
p
8–
11
 (n
=2
4)
11
–1
4 
(n
=2
1)
14
–1
7 
(n
=5
4)
17
–2
0 
(n
=4
6)
20
–2
3 
(n
=4
5)
Pr
oc
es
sin
g 
Sp
ee
d
35
.1
1(±
8.2
4)
43
.8
6(±
6.5
1)
51
.8
8(±
7.6
5)
53
.9
2(±
7.8
5)
54
.9
2(±
7.6
2)
F(
1,1
83
)=
19
.22
p<
.0
01
A
tte
nt
io
n/
V
ig
ila
nc
e
35
.8
2(±
6.9
1)
43
.4
3(±
8.6
7)
50
.7
9(±
6.7
3)
54
.2
7(±
6.6
9)
56
.8
0(±
8.5
5)
F(
1,1
76
)=
8.3
7
p<
.0
1
W
or
ki
ng
 M
em
or
y
39
.2
8(±
10
.95
)
47
.1
2(±
7.4
7)
50
.2
3(±
8.5
4)
53
.2
7(±
9.6
1)
53
.6
6(±
7.6
6)
F(
1,1
84
)=
6.6
2
p<
.0
1
V
er
ba
l L
ea
rn
in
g
43
.0
8(±
12
.27
)
48
.7
2(±
11
.05
)
50
.2
5(±
10
.05
)
51
.9
0(±
7.3
6)
51
.3
1(±
9.0
3)
F(
1,1
84
)=
3.9
7
p<
.0
5
V
isu
al
 L
ea
rn
in
g
42
.6
4(±
11
.84
)
48
.2
6(±
12
.03
)
51
.6
6(±
8.2
6)
52
.2
6(±
9.0
7)
49
.5
2(±
8.6
0)
F(
1,1
79
)=
9.9
5
P<
.0
1
R
ea
so
ni
ng
/P
ro
bl
em
 S
ol
vi
ng
38
.3
9(±
9.6
7)
50
.1
2(±
10
.93
)
50
.6
9(±
8.8
2)
53
.1
9(±
8.6
5)
51
.5
9(±
8.1
0)
F(
1,1
82
)=
18
.28
p<
.0
01
O
ve
ra
ll 
Co
m
po
sit
e
34
.7
2(±
9.1
7)
46
.3
3(±
8.2
7)
51
.6
9(±
7.3
8)
53
.8
6(±
7.0
3)
53
.7
3(±
8.1
2)
F(
1,1
73
)=
26
.48
p<
.0
01
M
C
C
B 
R
eg
re
ss
io
n-
Ba
se
d 
T-
Sc
or
e
Pr
oc
es
sin
g 
Sp
ee
d
44
.9
7(±
10
.82
)
50
.2
8(±
7.4
5)
53
.9
0(±
9.3
9)
51
.6
2(±
9.9
1)
45
.8
8(±
9.1
7)
F(
1,1
82
)=
21
.18
p<
.0
01
A
tte
nt
io
n/
V
ig
ila
nc
e
46
.5
1(±
8.3
4)
49
.9
1(±
11
.68
)
53
.0
3(±
9.0
9)
50
.7
8(±
8.7
7)
47
.3
2(±
11
.47
)
F(
1,1
76
)=
8.8
4
p<
.0
1
W
or
ki
ng
 M
em
or
y
46
.9
2(±
12
.21
)
51
.9
6(±
8.7
8)
51
.4
3(±
9.4
5)
51
.0
1(±
10
.71
)
47
.8
1(±
8.6
5)
F(
1,1
84
)=
6.6
6
p≤
.0
1
V
er
ba
l L
ea
rn
in
g
47
.3
7(±
12
.53
)
51
.3
1(±
11
.48
)
51
.1
1(±
10
.39
)
50
.9
4(±
7.7
8)
48
.3
7(±
9.1
5)
F(
1,1
84
)=
4.1
4
p<
.0
5
V
isu
al
 L
ea
rn
in
g
46
.0
4(±
11
.83
)
50
.3
1(±
12
.23
)
52
.5
0(±
8.6
9)
51
.6
7(±
9.3
9)
47
.0
4(±
8.8
0)
F(
1,1
79
)=
10
.75
p≤
.0
01
R
ea
so
ni
ng
/P
ro
bl
em
 S
ol
vi
ng
45
.0
6(±
10
.24
)
54
.8
2(±
11
.75
)
51
.7
4(±
9.9
8)
51
.2
2(±
8.5
5)
46
.7
6(±
8.6
4)
F(
1,1
82
)=
17
.55
p<
.0
01
O
ve
ra
ll 
Co
m
po
sit
e
44
.2
0(±
10
.24
)
52
.8
6(±
11
.00
)
53
.5
2(±
8.5
1)
51
.5
7(±
8.4
6)
45
.6
5(±
10
.29
)
F(
1,1
73
)=
25
.97
p<
.0
01
No
te
: C
om
m
un
ity
-s
am
pl
e-
ba
se
d 
T-
sc
or
es
 u
se
 a
 c
al
cu
la
tio
n 
th
at
 is
 c
om
m
on
 a
cr
os
s a
ll 
ag
es
, w
he
re
 sc
or
es
 a
re
 d
er
iv
ed
 fr
om
 c
om
m
un
ity
 sa
m
pl
e 
m
ea
ns
 a
nd
 st
an
da
rd
 d
ev
ia
tio
ns
. R
eg
re
ss
io
n-
ba
se
d 
T-
sc
or
es
 u
se
a 
ca
lc
ul
at
io
n 
th
at
 a
dju
sts
 fo
r a
ge
, w
he
re 
sco
res
 ar
e c
om
pu
ted
 by
 re
gre
ssi
ng
 ag
e a
nd
 se
x o
n s
ub
tes
t ra
w 
sco
res
 to
 pr
od
uc
e p
red
ict
ed
 va
lue
s t
ha
t a
re 
sub
tra
cte
d f
rom
 ea
ch
 su
bte
st 
raw
 sc
ore
 be
for
e c
on
ve
rtin
g t
o
T-
sc
or
es
.
Schizophr Res. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Nitzburg et al. Page 13
Ta
bl
e 
3
Se
x 
ef
fe
ct
s o
n 
M
CC
B 
do
m
ai
ns
M
C
C
B 
T-
Sc
or
es
Se
x:
 U
na
dju
ste
d M
ea
ns
 (±
SD
)
St
at
ist
ic
p
M
al
e 
(n
=8
9)
Fe
m
al
e 
(n
=1
01
)
Pr
oc
es
sin
g 
Sp
ee
d
50
.3
0(±
9.5
1)
49
.6
5(±
10
.53
)
t(2
,18
2)=
 0.
44
n
s
A
tte
nt
io
n/
V
ig
ila
nc
e
51
.2
8(±
9.7
8)
49
.2
9(±
10
.14
)
t(2
,17
5)=
 1.
32
n
s
W
or
ki
ng
 M
em
or
y
51
.2
3(±
10
.99
)
48
.8
2(±
8.7
8)
t(2
,18
3)=
 1.
66
n
s
V
er
ba
l L
ea
rn
in
g
49
.7
3(±
10
.38
)
49
.8
3(±
9.6
6)
t(2
,18
3)=
 −0
.06
n
s
V
isu
al
 L
ea
rn
in
g
49
.0
0(±
11
.04
)
50
.4
7(±
8.8
0)
t(2
,17
8)=
 −0
.99
n
s
R
ea
so
ni
ng
/P
ro
bl
em
 S
ol
vi
ng
52
.3
1 
(±
9.6
9)
47
.6
2(±
9.8
3)
t(2
,18
1)=
 3.
24
p≤
.0
01
O
ve
ra
ll 
Co
m
po
sit
e
51
.1
9(±
10
.38
)
48
.8
6(±
9.4
4)
t(2
,17
2)=
 1.
55
n
s
No
te
: T
-s
co
re
s w
er
e 
de
riv
ed
 fr
om
 c
om
m
un
ity
 sa
m
pl
e 
m
ea
ns
 a
nd
 st
an
da
rd
 d
ev
ia
tio
ns
.
Schizophr Res. Author manuscript; available in PMC 2015 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Nitzburg et al. Page 14
Ta
bl
e 
4
M
CC
B 
su
bt
es
t r
aw
 sc
or
e 
m
ea
ns
 b
y 
ag
e 
gr
ou
p 
an
d 
se
x
M
C
C
B
R
aw
 S
co
re
s
A
ge
 G
ro
up
s:
 U
na
dju
ste
d M
ea
ns
 (±
SD
)
8–
11
 (n
=2
4)
11
–1
4 
(n
=2
1)
14
–1
7 
(n
=5
4)
17
–2
0 
(n
=4
6)
20
–2
3 
(n
=4
5)
B
A
CS
 S
ym
bo
l C
od
in
g
40
.0
0(±
7.6
4)
51
.5
2(±
8.3
2)
60
.5
8(±
8.0
6)
63
.0
9(±
8.4
8)
64
.3
4(±
9.3
6)
A
ni
m
al
 N
am
in
g
17
.4
2(±
6.0
9)
20
.2
9(±
3.5
9)
22
.0
7(±
4.5
3)
23
.5
0(±
4.8
1)
23
.0
7(±
5.1
1)
Tr
ai
l M
ak
in
g 
Te
st 
A
*
42
.9
4(±
17
.74
)
34
.2
6(±
8.5
5)
28
.0
8(±
9.2
7)
26
.9
2(±
10
.79
)
25
.5
1(±
8.3
8)
CP
T-
IP
: D
Pr
im
e 
A
ve
ra
ge
1.
12
(±
0.5
6)
1.
74
(±
0.7
0)
2.
33
(±
0.5
4)
2.
61
(±
0.5
4)
2.
82
(±
0.6
9)
W
M
S 
Sp
at
ia
l S
pa
n
13
.5
8(±
3.5
9)
15
.1
0(±
2.5
9)
16
.1
9(±
3.0
5)
16
.6
4(±
3.5
7)
16
.8
3(±
2.2
1)
Le
tte
r-
N
um
be
r S
pa
n
10
.2
5(±
3.3
5)
13
.1
9(±
2.8
4)
13
.8
7(±
2.8
0)
15
.1
3(±
3.0
1)
15
.1
7(±
2.6
5)
H
V
LT
-R
22
.5
4(±
4.9
3)
24
.8
1(±
4.4
5)
25
.4
3(±
4.0
4)
26
.0
9(±
2.9
6)
25
.8
5(±
3.6
3)
B
V
M
T-
R
21
.7
4(±
6.7
7)
24
.9
5(±
6.8
8)
26
.9
0(±
4.7
3)
27
.2
4(±
5.1
9)
25
.6
8(±
4.9
2)
N
A
B 
M
az
es
12
.5
0(±
5.4
4)
19
.1
0(±
6.1
5)
19
.4
2(±
4.9
6)
20
.8
2(±
4.8
6)
19
.9
3(±
4.5
5)
M
C
C
B
R
aw
 S
co
re
s
Se
x:
 U
na
dju
ste
d M
ea
ns
 (±
SD
)
M
al
e 
(n
=8
9)
Fe
m
al
e 
(n
=1
01
)
B
A
CS
 S
ym
bo
l C
od
in
g
57
.8
5(±
12
.02
)
58
.7
2(±
11
.25
)
A
ni
m
al
 N
am
in
g
22
.2
7(±
5.3
6)
21
.5
0(±
5.0
5)
Tr
ai
l M
ak
in
g 
Te
st 
A
*
28
.3
9(±
10
.91
)
30
.9
5(±
12
.95
)
CP
T-
IP
: D
Pr
im
e 
A
ve
ra
ge
2.
37
(±
0.7
9)
2.
21
(±
0.8
2)
W
M
S 
Sp
at
ia
l S
pa
n
16
.2
1(±
3.8
0)
15
.7
8(±
2.5
5)
Le
tte
r-
N
um
be
r S
pa
n
14
.4
1(±
3.4
3)
13
.4
8(±
3.1
0)
H
V
LT
-R
25
.2
2(±
4.1
7)
25
.2
6(±
3.8
8)
B
V
M
T-
R
25
.3
8(±
6.3
2)
26
.2
2(±
5.0
3)
N
A
B 
M
az
es
20
.3
3(±
5.4
5)
17
.6
9(±
5.5
3)
*
Sc
or
es
 in
di
ca
te
 c
om
pl
et
io
n 
tim
es
; h
ig
he
r s
co
re
s d
en
ot
e 
slo
w
er
 p
ro
ce
ss
in
g 
sp
ee
d.
Schizophr Res. Author manuscript; available in PMC 2015 January 01.
